Literature DB >> 4948427

Clinical trials of anti-epileptic drugs.

H Meinardi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4948427

Source DB:  PubMed          Journal:  Psychiatr Neurol Neurochir        ISSN: 0033-2666


× No keyword cloud information.
  8 in total

1.  Effect of sodium valproate on plasma protein binding of diphenylhydantoin.

Authors:  P N Patsalos; P T Lascelles
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-06       Impact factor: 10.154

2.  Single and chronic dose pharmacokinetic studies of sodium valproate in epileptic patients.

Authors:  G W Mihaly; F J Vajda; J L Miles; W J Louis
Journal:  Eur J Clin Pharmacol       Date:  1979-08       Impact factor: 2.953

3.  Controlled trial of sodium valproate in severe epilepsy.

Authors:  A Richens; S Ahmad
Journal:  Br Med J       Date:  1975-11-01

4.  Treatment of childhood epilepsy with dipropylacetic acid (DPA).

Authors:  I Lagenstein; H J Sternowsky; E Blaschke; M Rothe; R Fehr
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-10-09

5.  Pharmacokinetics of di-n-propylacetate in epileptic patients.

Authors:  F Schobben; E van der Kleijn; F J Gabreëls
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

Review 6.  Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-02       Impact factor: 9.546

7.  Effect of di-n-propylacetate on the 'binding of GABA to synaptosome-enriched fraction of rat cerebral cortex.

Authors:  B M Kulig; C Gonzalez-Portal; E Somoza; F V Defeudis
Journal:  Psychopharmacology (Berl)       Date:  1977-08-16       Impact factor: 4.530

8.  Disposition of valproic acid in man.

Authors:  R Gugler; A Schell; M Eichelbaum; W Fröscher; H U Schulz
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.